Chinese Club Moss Extract (Huperzine A) May Improve Cognition In Alzheimer’s...
Existing evidence suggests that patients with Alzheimer's disease who have taken Huperzine A have improved general cognitive function, global clinical status, functional performance and...
Natural Alzheimer’s-Fighting Compound Created Inexpensively in Lab
Scientists at Yale University have developed the first practical method to create a compound called huperzine A in the lab. The compound, which occurs...
Building a Better Antipsychotic Drug by Treating Schizophrenia’s Cause: How Drugs...
The classic symptoms of schizophrenia -- paranoia, hallucinations, the inability to function socially -- can be managed with antipsychotic drugs. But exactly how these...
Protein Linked To Parkinson’s Disease May Regulate Fat Metabolism
National Institutes of Health researchers have found that Parkin, an important protein linked with some cases of early-onset Parkinson's disease, regulates how cells in our bodies take up and process dietary fats.
Nicotine Can Protect The Brain From Parkinson’s Disease, Research Suggests
If you've ever wondered if nicotine offered society any benefit, a new study published in The FASEB Journal offers a surprising answer. Nicotine can protect the brain against Parkinson's disease, the research suggests, and the discovery of how nicotine does this may lead to entirely new types of treatments for the disease.
Over Half of Alzheimer’s Cases May Be Preventable, Say Researchers
Over half of all Alzheimer's disease cases could potentially be prevented through lifestyle changes and treatment or prevention of chronic medical conditions, according to a study led by Deborah Barnes, PhD, a mental health researcher at the San Francisco VA Medical Center.
Falls May Be Early Sign Of Alzheimer’s
Falls and balance problems may be early indicators of Alzheimer's disease, researchers at Washington University School of Medicine in St. Louis report July 17, 2011, at the Alzheimer's Association International Conference on Alzheimer's Disease in Paris.
Patients Who Use Anti-Depressants Are More Likely To Suffer Relapse, Researcher...
Patients who use anti-depressants are much more likely to suffer relapses of major depression than those who use no medication at all, concludes a McMaster researcher. In a paper that is likely to ignite new controversy in the hotly debated field of depression and medication, evolutionary psychologist Paul Andrews concludes that patients who have used anti-depressant medications can be nearly twice as susceptible to future episodes of major depression.
Physical Activity Linked To Lower Rates Of Cognitive Impairment
Engaging in regular physical activity is associated with less decline in cognitive function in older adults, according to two studies published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. The articles are being released on July 19 to coincide with the International Conference on Alzheimer's Disease in Paris and will be included in the July 25 print edition.
Is Meditation The Push-Up for the Brain? May Have Potential To...
Two years ago, researchers at UCLA found that specific regions in the brains of long-term meditators were larger and had more gray matter than the brains of individuals in a control group. This suggested that meditation may indeed be good for all of us since, alas, our brains shrink naturally with age.
Chinese Medicine Offers New Parkinson’s Treatments
A hooked herb, root extract and a dash of bark – it may sound like a witches' brew, but these compounds could provide treatments for diseases that have so far foiled western doctors, such as Parkinson's and irritable bowel syndrome. For over 2000 years Chinese doctors have treated "the shakes" – now known as Parkinson's disease – with gou teng, a herb with hook-like branches.
Lithium Prevents Brain Damage Associated With Parkinson’s Disease
Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition. Preclinical research is now underway at the Buck Institute for Research on Aging to determine correct dosages for a drug that continues to be the gold standard for the treatment of bipolar disorder.